What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Gene
Her primary areas of study are Internal medicine, Cancer, Gastroenterology, Cancer research and Immunology.
Her studies in Internal medicine integrate themes in fields like Surgery, Oncology and Pathology.
Her Oncology research focuses on Temsirolimus and how it connects with Sirolimus.
Razelle Kurzrock interconnects Malignancy, Carcinoma, Personalized medicine, Biomarker and Lung cancer in the investigation of issues within Cancer.
Her Gastroenterology study combines topics in areas such as Pharmacokinetics, Survival rate, Interferon alfa, Lymphoma and Leukemia.
Her Cancer research research also works with subjects such as
- Mutation that connect with fields like Protein kinase B,
- Chromosomal translocation which is related to area like ABL.
Her most cited work include:
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy (1085 citations)
- The biology of chronic myeloid leukemia (1077 citations)
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers. (1012 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Internal medicine, Oncology, Cancer, Cancer research and Gastroenterology.
Her Internal medicine study combines topics from a wide range of disciplines, such as Surgery and Pharmacology.
The Oncology study combines topics in areas such as Bevacizumab, Breast cancer, Melanoma and Immunotherapy.
Her Cancer study integrates concerns from other disciplines, such as Phases of clinical research, Lung cancer, Pathology and Bioinformatics.
Her work deals with themes such as Mutation, Chronic myelogenous leukemia, Protein kinase B and PI3K/AKT/mTOR pathway, which intersect with Cancer research.
Her study in Gastroenterology is interdisciplinary in nature, drawing from both Toxicity, Neutropenia, Chemotherapy, Immunology and Nausea.
She most often published in these fields:
- Internal medicine (53.41%)
- Oncology (31.09%)
- Cancer (30.71%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (53.41%)
- Oncology (31.09%)
- Cancer research (23.07%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Oncology, Cancer research, Cancer and Immunotherapy.
Her study connects Gastroenterology and Internal medicine.
Her research in Oncology focuses on subjects like Targeted therapy, which are connected to Combination therapy.
Her work carried out in the field of Cancer research brings together such families of science as Immune checkpoint, Cell, Gene and Immune checkpoint inhibitors.
Her research investigates the connection between Cancer and topics such as Biopsy that intersect with issues in Standardized uptake value.
Razelle Kurzrock has included themes like Nivolumab, Ipilimumab and Phases of clinical research in her Clinical endpoint study.
Between 2017 and 2021, her most popular works were:
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors (398 citations)
- Targeted therapy for advanced solid tumors on the basis of molecular profiles: Results from mypathway, an open-label, phase IIA multiple basket study (200 citations)
- Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study (195 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Razelle Kurzrock spends much of her time researching Internal medicine, Oncology, Cancer research, Cancer and Immunotherapy.
Her studies deal with areas such as Gastroenterology and Precision medicine as well as Internal medicine.
Her Oncology research includes themes of Targeted therapy, Breast cancer, Colorectal cancer and Phases of clinical research.
Her research in Cancer research intersects with topics in Immune checkpoint, Biomarker and Gene, GNAS complex locus.
The study incorporates disciplines such as Sarcoma and Hazard ratio in addition to Cancer.
She has researched Immunotherapy in several fields, including Mutation, Blockade, Melanoma and Microsatellite instability.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
